Predictive value of angiopoietin-like protein 8 in metabolic dysfunction-associated fatty liver disease and its progression: A case-control study

Table 3 Multifactor logistic regression analysis of factors influencing metabolic dysfunction-associated fatty liver disease

	B	S.E.	Wals	P valuea	EXP(B)	95%CI
ANGPTL8	0.116	0.027	19.118	< 0.001	1.123	1.066-1.184
BMI	0.275	0.111	6.142	0.013	1.317	1.059-1.637
ALT	0.032	0.021	2.394	0.122	1.032	0.992-1.075
HDL-C	-0.386	0.804	0.231	0.631	0.680	0.141-3.287
FINS	0.085	0.091	0.875	0.350	1.088	0.911-1.300
HbA1c	-0.248	0.176	1.982	0.159	0.780	0.552-1.102
HOMA-IR	-0.426	0.251	2.869	0.090	0.653	0.399-1.069
CRP	0.160	0.088	3.285	0.070	1.173	0.987-1.395
WHR	-3.793	4.066	0.870	0.351	0.023	0.000-65.098
TG	2.255	0.527	18.277	< 0.001	9.532	3.391-26.800

^aP < 0.05 is considered significant.

CI: Confidence interval; ANGPTL8: Angiopoietin-like protein 8; BMI: Body mass index; ALT: Alanine transaminase; HDL-C: High-density lipoprotein-cholesterol; FINS: Fasting insulin; HbA1c: Glycated hemoglobin; HOMA-IR: Homeostasis model assessment of insulin resistance; CRP: C-reactive protein; WHR: Waist-to-hip ratio; TG: Triglyceride.